A charge nurse on a medical-surgical unit is anticipating an emergency response plan following an external disaster in the community. Which of the following current clients should the nurse recommend for early discharge?

Choice A reason: Taking diuretics with the evening meal increases nighttime urination, worsening urge incontinence by stimulating bladder activity during sleep. Diuretics should be taken earlier (e.g., morning) to align with daytime voiding schedules, reducing urgency episodes. This instruction is counterproductive for bladder retraining, making it inappropriate.
Choice B reason: Planning to urinate every 3 hours while awake establishes a scheduled voiding regimen, a key component of bladder retraining. This helps condition the bladder to delay urgency, reducing involuntary contractions and improving control. It aligns with evidence-based strategies for managing urge incontinence, making it the correct instruction.
Choice C reason: Limiting fluid intake to 1 liter per day risks dehydration and concentrated urine, which can irritate the bladder and worsen urge incontinence. Adequate hydration (2-3 L/day) supports bladder health and retraining by maintaining normal urine volume, making this instruction harmful and incorrect.
Choice D reason: Performing Kegel exercises once daily is insufficient for effective bladder retraining. Multiple daily sets (e.g., 3-4 times) strengthen pelvic floor muscles, improving bladder control. This frequency is too low to achieve therapeutic benefits for urge incontinence, making it less effective than scheduled voiding.

Choice A reason: Bleeding time assesses platelet function, not warfarin’s anticoagulant effect. Warfarin inhibits vitamin K-dependent clotting factors, unrelated to platelets. Monitoring bleeding time does not reflect therapeutic anticoagulation levels, making it irrelevant for adjusting warfarin doses to prevent thrombosis or bleeding.
Choice B reason: Factor VIII, deficient in hemophilia A, is not affected by warfarin, which targets vitamin K-dependent factors (II, VII, IX, X). Measuring Factor VIII does not indicate warfarin’s efficacy, as it is unrelated to the drug’s mechanism, making it unsuitable for dose monitoring.
Choice C reason: aPTT monitors heparin’s effect on the intrinsic clotting pathway, not warfarin’s action on vitamin K-dependent factors. Warfarin requires INR for therapeutic monitoring, as aPTT is insensitive to its effects, making it inappropriate for assessing warfarin’s anticoagulation range in patients.
Choice D reason: INR standardizes prothrombin time, measuring warfarin’s effect on vitamin K-dependent clotting factors. It ensures therapeutic anticoagulation (e.g., INR 2-3), preventing thrombosis or bleeding. INR is the gold standard for warfarin monitoring, guiding dose adjustments for safe and effective therapy.